Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study

Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study

Show other versions (1)

Objective: We aimed to understand the molecular pathways affected by bortezomib and arsenic trioxide treatment on myelomonocytoid cell line P39. Materials and Methods: Oligonucleotide microarray platforms were used for gene expression and pathway analysis. Confirmation studies were performed using...

Full description

Bibliographic Details
Main Authors: Hakan Savlı, Sara Galimberti, Deniz Sünnetçi, Martina Canestraro, Giuseppe Palumbo, Balint Nagy, Francesco Di Raimondo, Mario Petrini
Format: Article
Language:English
Published: Galenos Publishing House 2015-09-01
Series:Turkish Journal of Hematology
Subjects:
Bortezomib
Arsenic trioxide
NF-κB
MDS
Gene expression
Online Access:http://www.tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-78309&look4=

Internet

http://www.tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-78309&look4=

Similar Items